Plunkett Research Online: Therapix Biosciences

THERAPIX BIOSCIENCES (TRPX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company is developing THX-110 targeted to the treatment of Tourette Syndrome and THX-130 targeted to th.....



Therapix Biosciences
Ticker: TRPX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 89396577
Fax: 972 89396574
Address: 4 Ariel Sharon Street
HaShahar Tower, 16th Floor
Givatayim, 5320047 Israel

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription
Oz AdlerCFO
Ascher ShmulewitzChairman of the Board/Director/CEO
See More
Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company is developing THX-110 targeted to the treatment of Tourette Syndrome and THX-130 targeted to th.....See More See More

Auditor: Kost Forer Gabbay & Kasierer
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: